The manufacturer of calcipotriol cream (Dovonex®) has advised that this product has been discontinued for economic reasons.
The Psoriasis Association note that there are no safety or quality concerns. Current supplies of the cream can continue to be dispensed and used.
Calcipotriol ointment remains available, both as a generic product and as Dovonex. This may be a suitable alternative after consideration of patient acceptability of a greasier product.
Action: Clinicians should be aware of this product discontinuation and make arrangements to switch patients to suitable alternatives.
|« HPV vaccine to change from September 2012||SSRI learning module »|